Hanik KholidahIn a significant leap forward for the field of synthetic biology and precision medicine, researchers at Texas A&M University have unveiled a groundbreaking method to control gene-editing tools and therapeutic…
Susilo Wagino MulyoThe emergence of Glucagon-like peptide-1 (GLP-1) receptor agonists, initially heralded for their efficacy in managing type 2 diabetes, has dramatically reshaped discussions around weight loss and, more recently, the treatment…
Susilo Wagino MulyoThe emergence of Glucagon-like peptide-1 receptor agonists (GLP-1s), such as Ozempic, Wegovy, and Zepbound, has introduced a new paradigm in the management of chronic conditions, particularly type 2 diabetes and…
Hanik KholidahIn a landmark development for cardiovascular and neurological medicine, the newly released C-CHANGE/CMAJ 2026 clinical guidelines have officially recognized the bidirectional relationship between the human heart and the brain. This…
Susilo Wagino MulyoThe landscape of sleep apnea treatment is undergoing a significant evolution with the emergence of Glucagon-like Peptide-1 (GLP-1) receptor agonists, a class of medications initially developed for type 2 diabetes…
